Search research articles
Contact Us
Filters
Showing results (11-20 of 202) with videos related to
Page
of 21
Sort By:
Inflammatory Bowel Diseases
|
November 6, 2010
Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: big news or big deal?
Adam S Cheifetz, Laura Rosenberg
The American Journal of Gastroenterology
|
February 22, 2017
Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
Konstantinos Papamichael, Adam S Cheifetz
Current Opinion in Gastroenterology
|
April 12, 2019
Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?
Konstantinos Papamichael, Adam S Cheifetz
Alimentary Pharmacology & Therapeutics
|
November 19, 2024
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Konstantinos Papamichael, Adam S Cheifetz
World Journal of Gastroenterology
|
October 5, 2017
Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy
Konstantinos Papamichael, Adam S Cheifetz
Journal of Crohn'S & Colitis
|
November 26, 2019
Proactive Adalimumab Monitoring in Inflammatory Bowel Disease: Current Data and Future Perspectives
Konstantinos Papamichael, Adam S Cheifetz
Frontline Gastroenterology
|
August 26, 2017
Use of anti-TNF drug levels to optimise patient management
Konstantinos Papamichael, Adam S Cheifetz
The American Journal of Gastroenterology
|
December 8, 2017
Response to Reinink
Konstantinos Papamichael, Adam S Cheifetz
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 28, 2020
Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Konstantinos Papamichael, Adam S Cheifetz
Mayo Clinic Proceedings
|
June 12, 2017
Crohn Disease: Epidemiology, Diagnosis, and Management
Joseph D Feuerstein, Adam S Cheifetz
Page
of 21
Search research articles
Search
Showing results (11-20 of 202) with videos related to
Sort By:
Page
of 21
Inflammatory Bowel Diseases
|
November 6, 2010
Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: big news or big deal?
Adam S Cheifetz, Laura Rosenberg
The American Journal of Gastroenterology
|
February 22, 2017
Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
Konstantinos Papamichael, Adam S Cheifetz
Current Opinion in Gastroenterology
|
April 12, 2019
Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?
Konstantinos Papamichael, Adam S Cheifetz
Alimentary Pharmacology & Therapeutics
|
November 19, 2024
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Konstantinos Papamichael, Adam S Cheifetz
World Journal of Gastroenterology
|
October 5, 2017
Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy
Konstantinos Papamichael, Adam S Cheifetz
Journal of Crohn'S & Colitis
|
November 26, 2019
Proactive Adalimumab Monitoring in Inflammatory Bowel Disease: Current Data and Future Perspectives
Konstantinos Papamichael, Adam S Cheifetz
Frontline Gastroenterology
|
August 26, 2017
Use of anti-TNF drug levels to optimise patient management
Konstantinos Papamichael, Adam S Cheifetz
The American Journal of Gastroenterology
|
December 8, 2017
Response to Reinink
Konstantinos Papamichael, Adam S Cheifetz
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 28, 2020
Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Konstantinos Papamichael, Adam S Cheifetz
Mayo Clinic Proceedings
|
June 12, 2017
Crohn Disease: Epidemiology, Diagnosis, and Management
Joseph D Feuerstein, Adam S Cheifetz
Page
of 21